FDA Clearance Tracker · K242775
InPen System App (MMT-8060 (iOS), MMT-8061 (Android))
Last checked: Nov 20, 2026Latest source record: Nov 12, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 12, 2024
Substantially Equivalent
Time to decision
60 days
Received Sep 13, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K242775
- Device name
- InPen System App (MMT-8060 (iOS), MMT-8061 (Android))
- Applicant
- Medtronic Minimed
- Applicant location
- Northridge, CA
- Received
- Sep 13, 2024
- Decided
- Nov 12, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Calculator, Drug Dose (NDC)
- Device class
- Class II
- Regulation
- 21 CFR 868.1890
- Specialty
- Anesthesiology & Respiratory
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NDC. The earliest in FDA's data is K851573, decided Jan 8, 1986.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K242775
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Medtronic Minimed
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261962 · Decided Jul 9, 2026 · 28 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
- MiniMed Flex pump510(k)
K253743 · Decided Mar 12, 2026 · 108 days after receipt
Device type: Alternate Controller Enabled Insulin Infusion Pump (QFG) · Laboratory Medicine & Pathology
K253701 · Decided Feb 3, 2026 · 71 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.